FDA Live-Streams Cancer Trials From AstraZeneca and Amgen — May 4, 2026

The FDA just turned on a live data feed inside two cancer trials.Run time: 15:06In today's episode:FDA pilots live cancer-trial data feedBMI-free obesity-risk model spans 18 conditionsTopol slams medical-AI implementation paradoxNEJM Catalyst declares the proof era for digital healthnpj review finds bias in AI medical-education imagesEU AI Act medical deadline shifts toward 2027npj DM perspective on EHR generative-AI traceabilityClaude Code ultrareview free preview ends May 5Claude Code ships project purge and gateway model pickerUC Berkeley shows agent benchmarks reward-hackable to 100%TL;DR:FDA opened its first live data feed into two AstraZeneca and Amgen cancer trials, projecting 20–40% timeline savings if expanded.A new Nature Medicine machine-learning model called OBSCORE risk-stratifies adults for 18 obesity-related complications using twenty everyday clinical features rather than BMI alone.Anthropic's Claude Code /ultrareview public preview is free through May 5; afterwards it bills $5–$20 per multi-agent cloud review.Sources cited:STATNature MedicineGround Truths SubstackNEJM Catalystnpj Digital MedicinePetrie-Flom Centernpj Digital MedicineAnthropic changelogReleasebot Anthropic feedBerkeley researchSubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.